Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;59(6):3570-3.
doi: 10.1128/AAC.04922-14. Epub 2015 Mar 16.

Implication of Candida parapsilosis FKS1 and FKS2 mutations in reduced echinocandin susceptibility

M Martí-Carrizosa  1 , F Sánchez-Reus  2 , F March  3 , E Cantón  4 , P Coll  1
Affiliations

Implication of Candida parapsilosis FKS1 and FKS2 mutations in reduced echinocandin susceptibility

M Martí-Carrizosa et al. Antimicrob Agents Chemother. 2015.

Abstract

We evaluated FKS1 and FKS2 mutations in Candida parapsilosis bloodstream isolates and correlated them with the echinocandin MIC values determined by guidelines in CLSI document M27-A3 and the YeastOne panel. All mutations detected were outside hot spot (HS) regions. The F1386S mutation detected in an isolate that was resistant by the YeastOne panel but not by the M27-A3 guidelines might be implicated in echinocandin resistance. Further studies are needed to confirm the implication of the F1386S mutation and to elucidate the capability of the M27-A3 guidelines to detect echinocandin resistance.

PubMed Disclaimer

References

    1. Douglas CM, D'Ippolito JA, Shei GJ, Meinz M, Onishi J, Marrinan JA, Li W, Abruzzo GK, Flattery A, Bartizal K, Mitchell A, Kurtz MB. 1997. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-d-glucan synthase inhibitors. Antimicrob Agents Chemother 41:2471–2479. - PMC - PubMed
    1. Lewis JS Jr, Wiederhold NP, Wickes BL, Patterson TF, Jorgensen JH. 2013. Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure. Antimicrob Agents Chemother 57:4559–4561. doi:10.1128/AAC.01144-13. - DOI - PMC - PubMed
    1. Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. 2013. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56:1724–1732. doi:10.1093/cid/cit136. - DOI - PMC - PubMed
    1. Jensen RH, Justesen US, Rewes A, Perlin DS, Arendrup MC. 2014. Echinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei. Antimicrob Agents Chemother 58:3550–3552. doi:10.1128/AAC.02367-14. - DOI - PMC - PubMed
    1. Imtiaz T, Lee KK, Munro CA, Maccallum DM, Shankland GS, Johnson EM, Macgregor MS, Bal AM. 2012. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin. J Med Microbiol 61:1330–1334. doi:10.1099/jmm.0.045047-0. - DOI - PubMed

LinkOut - more resources